0001437749-20-017701.txt : 20200812 0001437749-20-017701.hdr.sgml : 20200812 20200812183755 ACCESSION NUMBER: 0001437749-20-017701 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200806 FILED AS OF DATE: 20200812 DATE AS OF CHANGE: 20200812 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Anderson Bonnie H CENTRAL INDEX KEY: 0001588970 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36156 FILM NUMBER: 201096533 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERACYTE, INC. CENTRAL INDEX KEY: 0001384101 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 205455398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 243-6300 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: CALDEROME INC DATE OF NAME CHANGE: 20061219 4 1 rdgdoc.xml FORM 4 X0306 4 2020-08-06 0001384101 VERACYTE, INC. VCYT 0001588970 Anderson Bonnie H 6000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 1 1 Chairman and CEO Common Stock 2020-08-06 5 G 0 25000 0 D 247207 D Common Stock 2020-08-06 5 G 0 25000 0 D 222207 D Common Stock 2020-08-06 5 G 0 25000 0 A 25000 I The ANP Anderson Trust Common Stock 2020-08-06 5 G 0 25000 0 A 25000 I MJP Anderson Trust Common Stock 2020-08-10 4 M 0 20000 8.86 A 242207 D Common Stock 2020-08-10 4 M 0 20000 32.2239 D 222207 D Common Stock 99085 I The Bonnie H. Anderson Living Trust Stock Option (right to buy) 8.86 2020-08-10 4 M 0 20000 0 D 2025-03-02 Common Stock 20000 168312 D The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of her pecuniary interest therein, if any. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Represents weighted average sales price. Sale prices for the transactions range from $31.82 to $32.77. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. The option is fully vested. /s/ Keith Kennedy, as Attorney-in-fact 2020-08-12